Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Xenetic Biosciences Inc. (XBIO)

  • Company Report
  • March 22, 2023, 23:35 UTC
  • 46

New SEC Form for Xenetic Biosciences, Inc.

Comment Full text

Atossa Therapeutics Inc. (ATOS)

  • Company Report
  • March 22, 2023, 23:30 UTC
  • 47

Atossa Therapeutics SEC filing

Comment Full text

Atossa Therapeutics Inc. (ATOS)

  • Company Report
  • March 22, 2023, 23:29 UTC
  • 43

Atossa Therapeutics SEC filing

Comment Full text

Journey Medical Corporation (DERM)

  • Company Report
  • March 22, 2023, 16:05 UTC
  • 50

Journey Medical Corporation to Announce Year End 2022 Financial Results on March 29, 2023

Comment Full text

Luna Innovations Incorporated (LUNA)

  • Company Report
  • March 22, 2023, 15:39 UTC
  • 43

Fiber-based monitoring systems to support major clean energy project in Northeastern United States

Comment Full text

Chemomab Therapeutics Ltd. (CMMB)

  • Company Report
  • March 21, 2023, 13:20 UTC
  • 54

New SEC Filing for Chemomab Therapeutics Ltd. (NASDAQ:CMMB)

Comment Full text

Lipocine Inc. (LPCN)

  • Company Report
  • March 21, 2023, 00:55 UTC
  • 45

New SEC Filing for Lipocine Inc. (NASDAQ:LPCN)

Comment Full text

Graphite Bio Inc (GRPH)

  • Company Report
  • March 20, 2023, 23:15 UTC
  • 47

New SEC Form for Graphite Bio, Inc.

Comment Full text

Innoviva Inc (INVA)

  • Company Report
  • March 20, 2023, 23:15 UTC
  • 45

New Form 10-K/A for Innoviva, Inc.

Comment Full text

Lantern Pharma Inc. (LTRN)

  • Company Report
  • March 20, 2023, 23:10 UTC
  • 45

New SEC Form for Lantern Pharma Inc.

Comment Full text
  • Previous
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next

Search

News categories

  • Technical Exchange News(9309)
  • Event(407)
  • SEC News(150123)
  • FDA Approval(8569)
  • Company Report(721)
  • Business News(103322)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin